Brown Douglas Matthew 4
4 · NEOGENOMICS INC · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Brown Douglas Matthew
Chief Strategy Officer
Transactions
- Tax Payment
Common Stock
2022-03-02−867→ 76,379 total - Award
Common Stock
2022-03-01+35,030→ 77,246 total - Award
Stock Option (Right to Buy)
2022-03-01+85,519→ 85,519 totalExercise: $21.41Exp: 2029-03-01→ Common Stock (85,519 underlying)
Holdings
- 45,017
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying) - 26,378
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying)
Footnotes (5)
- [F1]On March 1, 2022, Mr. Brown was granted 35,030 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.
- [F3]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date.